BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 17244673)

  • 1. CD137 stimulation delivers an antigen-independent growth signal for T lymphocytes with memory phenotype.
    Zhu Y; Zhu G; Luo L; Flies AS; Chen L
    Blood; 2007 Jun; 109(11):4882-9. PubMed ID: 17244673
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 4-1BB-specific monoclonal antibody promotes the generation of tumor-specific immune responses by direct activation of CD8 T cells in a CD40-dependent manner.
    Miller RE; Jones J; Le T; Whitmore J; Boiani N; Gliniak B; Lynch DH
    J Immunol; 2002 Aug; 169(4):1792-800. PubMed ID: 12165501
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Self-reactive memory-phenotype CD8 T cells exhibit both MHC-restricted and non-MHC-restricted cytotoxicity: a role for the T-cell receptor and natural killer cell receptors.
    Dhanji S; Teh SJ; Oble D; Priatel JJ; Teh HS
    Blood; 2004 Oct; 104(7):2116-23. PubMed ID: 15178577
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulation of follicular dendritic cell networks by activated T cells: the role of CD137 signaling.
    Sun Y; Blink SE; Chen JH; Fu YX
    J Immunol; 2005 Jul; 175(2):884-90. PubMed ID: 16002686
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of CD4 T cell help and costimulation in CD8 T cell responses during Listeria monocytogenes infection.
    Shedlock DJ; Whitmire JK; Tan J; MacDonald AS; Ahmed R; Shen H
    J Immunol; 2003 Feb; 170(4):2053-63. PubMed ID: 12574376
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Direct CD137 costimulation of CD8 T cells promotes retention and innate-like function within nascent atherogenic foci.
    Xu MM; Ménoret A; Nicholas SE; Günther S; Sundberg EJ; Zhou B; Rodriguez A; Murphy PA; Vella AT
    Am J Physiol Heart Circ Physiol; 2019 Jun; 316(6):H1480-H1494. PubMed ID: 30978132
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interleukin (IL)-15 and IL-7 jointly regulate homeostatic proliferation of memory phenotype CD8+ cells but are not required for memory phenotype CD4+ cells.
    Tan JT; Ernst B; Kieper WC; LeRoy E; Sprent J; Surh CD
    J Exp Med; 2002 Jun; 195(12):1523-32. PubMed ID: 12070280
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CD134 Costimulation Couples the CD137 Pathway to Induce Production of Supereffector CD8 T Cells That Become IL-7 Dependent.
    Lee SJ; Rossi RJ; Lee SK; Croft M; Kwon BS; Mittler RS; Vella AT
    J Immunol; 2007 Aug; 179(4):2203-14. PubMed ID: 17675480
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antitumor efficacy of CD137 ligation is maximized by the use of a CD137 single-chain Fv-expressing whole-cell tumor vaccine compared with CD137-specific monoclonal antibody infusion.
    Zhang H; Knutson KL; Hellstrom KE; Disis ML; Hellstrom I
    Mol Cancer Ther; 2006 Jan; 5(1):149-55. PubMed ID: 16432173
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 4-1BB ligand-mediated costimulation of human T cells induces CD4 and CD8 T cell expansion, cytokine production, and the development of cytolytic effector function.
    Wen T; Bukczynski J; Watts TH
    J Immunol; 2002 May; 168(10):4897-906. PubMed ID: 11994439
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activation-induced CD137 is a fast assay for identification and multi-parameter flow cytometric analysis of alloreactive T cells.
    Litjens NH; de Wit EA; Baan CC; Betjes MG
    Clin Exp Immunol; 2013 Oct; 174(1):179-91. PubMed ID: 23750604
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CD137-mediated pathogenesis from chronic hepatitis to hepatocellular carcinoma in hepatitis B virus-transgenic mice.
    Wang J; Zhao W; Cheng L; Guo M; Li D; Li X; Tan Y; Ma S; Li S; Yang Y; Chen L; Wang S
    J Immunol; 2010 Dec; 185(12):7654-62. PubMed ID: 21059892
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 4-1BB ligand induces cell division, sustains survival, and enhances effector function of CD4 and CD8 T cells with similar efficacy.
    Cannons JL; Lau P; Ghumman B; DeBenedette MA; Yagita H; Okumura K; Watts TH
    J Immunol; 2001 Aug; 167(3):1313-24. PubMed ID: 11466348
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TLR2 engagement on memory CD8(+) T cells improves their cytokine-mediated proliferation and IFN-gamma secretion in the absence of Ag.
    Cottalorda A; Mercier BC; Mbitikon-Kobo FM; Arpin C; Teoh DY; McMichael A; Marvel J; Bonnefoy-Bérard N
    Eur J Immunol; 2009 Oct; 39(10):2673-81. PubMed ID: 19634192
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combined CD137 (4-1BB) and adjuvant therapy generates a developing pool of peptide-specific CD8 memory T cells.
    Myers L; Lee SW; Rossi RJ; Lefrancois L; Kwon BS; Mittler RS; Croft M; Vella AT
    Int Immunol; 2006 Feb; 18(2):325-33. PubMed ID: 16373363
    [TBL] [Abstract][Full Text] [Related]  

  • 16. IL-15 induces type 1 and type 2 CD4+ and CD8+ T cells proliferation but is unable to drive cytokine production in the absence of TCR activation or IL-12 / IL-4 stimulation in vitro.
    Niedbala W; Wei X; Liew FY
    Eur J Immunol; 2002 Feb; 32(2):341-7. PubMed ID: 11807773
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epigenetic remodeling of the IL-2 and IFN-gamma loci in memory CD8 T cells is influenced by CD4 T cells.
    Northrop JK; Thomas RM; Wells AD; Shen H
    J Immunol; 2006 Jul; 177(2):1062-9. PubMed ID: 16818762
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Memory CD8(+) T cells colocalize with IL-7(+) stromal cells in bone marrow and rest in terms of proliferation and transcription.
    Sercan Alp Ö; Durlanik S; Schulz D; McGrath M; Grün JR; Bardua M; Ikuta K; Sgouroudis E; Riedel R; Zehentmeier S; Hauser AE; Tsuneto M; Melchers F; Tokoyoda K; Chang HD; Thiel A; Radbruch A
    Eur J Immunol; 2015 Apr; 45(4):975-87. PubMed ID: 25639669
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IL-15-dependent induction of 4-1BB promotes antigen-independent CD8 memory T cell survival.
    Pulle G; Vidric M; Watts TH
    J Immunol; 2006 Mar; 176(5):2739-48. PubMed ID: 16493029
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preferential blockade of CD8(+) T cell responses by administration of anti-CD137 ligand monoclonal antibody results in differential effect on development of murine acute and chronic graft-versus-host diseases.
    Nozawa K; Ohata J; Sakurai J; Hashimoto H; Miyajima H; Yagita H; Okumura K; Azuma M
    J Immunol; 2001 Nov; 167(9):4981-6. PubMed ID: 11673505
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.